Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation

OBJECTIVES: The current gold-standard for the first-line treatment in IIIb/IV stages of epithelial ovarian cancer (EOC) is the combination of carboplatin and paclitaxel plus bevacizumab in some countries. In the era of personalized medicine, there is still uncertainty on the impact of several molecu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Staropoli, Nicoletta, Ciliberto, Domenico, Chiellino, Silvia, Caglioti, Francesca, Del Giudice, Teresa, Gualtieri, Simona, Salvino, Angela, Strangio, Alessandra, Botta, Cirino, Pignata, Sandro, Tassone, Pierfrancesco, Tagliaferri, Pierosandro
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347729/
https://ncbi.nlm.nih.gov/pubmed/27764790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados